Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 4 , Pages 244-248 , December 2007

Porfimer sodium photodynamic therapy in the treatment of early oesophageal carcinoma

References 

  1. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns of the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053
  2. Sharpe DAC, Moghissi K. Resectional surgery for carcinoma of the oesophagus and cardia. Eur J Cardiothorac Surg. 1996;10:359–364
  3. O’Donnell CA, Gray J, Hodgson H, Macpherson M, Zammit M, Fullarton G. A cost comparison of photodynamic therapy and metallic stent in the palliation of oesophageal carcinoma. Photodiagn Photodyn Ther. 2007;4:65–70
  4. May A, Gunter E, Roth F, Stolte M, Veith M, Ell C. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective and blinded trial. Gut. 2004;53:634–640
  5. Corti L, Skarlatos J, Boso C, et al. Outcomes of patients receiving photodynamic therapy for early oesophageal cancer. Int J Radiat Oncol Biol Phys. 2000;47:419–424
  6. Wolfsen HC, Hemminger LL, Raimondo M, Woodward TA. Photodynamic therapy and Endoscopic mucosal resection for Barrett's dysplasia and early oesophageal carcinoma. S Med J. 2004;97:827–831
  7. Wolfsen HC, Hemminger LL, Wallace MB, Devault KR. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther. 2004;20:1125–1131
  8. May A, Gossner L, Pech O, et al. Local endoscopic therapy for intraepithelial high grade neoplasia and early adenocarcinioma in Barrett's oesophagus; acute phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol. 2002;14:1085–1091
  9. Shaheen NJ, Inadomi JM, Overholt BF, Sharma P. What is the best management strategy for high grade dysplasia in Barrett's Oesophagus? A cost effectiveness analysis. Gut. 2004;53:1736–1744
  10. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's Esophagus: follow up in 100 patients. Gastrointest Endosc. 1999;49:1–7
  11. Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high grade dysplasia in Barrett's esophagus: international, partially blinded, randomised phase III trial. Gastrointest Endosc. 2005;62:488–498
  12. Panjehpour M, Bergein F, Overholt BF, et al. Optomization of light dosimetry for photodynamic therapy of Barrett's Esophagus: efficacy vs. incidence of stricture formation. Gastrointest Endosc. 2005;61:13–18
  13. Chan A, Wong A. Is combined chemotherapy and radiation equally effective as surgery in localised oesophageal carcinoma. Int J Radiat Oncol Biol Phys. 1999;45:265–270
  14. Mirikami M, Kuroda Y, Nakajima T, et al. Comparison between chemo radiation protocol for organ preservation and conventional surgery for clinical T1–T2 oesophageal carcinoma. Int J Radiat Oncol Biol Phys. 1999;45:275–284
  15. Polee MB, Hop WCJ, Kok TC, et al. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer. 2003;89:2045–2050

PII: S1572-1000(07)00097-X

doi: 10.1016/j.pdpdt.2007.09.003

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 4 , Pages 244-248 , December 2007

Article Tools